CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cε transcription in a human B cell line

被引:14
作者
Basaki, Y [1 ]
Ikizawa, K [1 ]
Kajiwara, K [1 ]
Yanagihara, Y [1 ]
机构
[1] Natl Sagamihara Hosp, Clin Res Ctr, Sagamihara, Kanagawa 2288522, Japan
关键词
CD40; TRAF3; ERK; MEK1; IL-4; germline C epsilon transcription;
D O I
10.1016/S0003-9861(02)00369-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Induction of germline Cepsilon transcription in B cells by IL-4, which is a critical initiating step for IgE class switching, is enhanced by CD40 engagement. Although signaling by CD40 is initiated by the binding of tumor necrosis factor receptor-associated factor (TRAF) family members to its cytoplasmic domain, whether those TRAF family proteins mediate enhancement of germline Cc transcription is not evident. We report here that CD40-induced TRAF3-dependent activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase 1 (MEK1) is involved in the upregulation of IL-4-driven germline Cepsilon transcription in a human Burkitt's lymphoma B cell line, DG75. Among the six known TRAF proteins, TRAF2, 3, 5. and 6 associated with CD40 in an unstimulated state, and the levels of these four proteins were unaffected by anti-CD40 stimulation. Antisense oligodeoxynucleotide (ODN) for TRAF3 inhibited CD40-induced activation of MEK1-ERK pathway by decreasing expression of TRAF3 protein, but antisense ODNs for TRAF2. 5, and 6 were ineffective. Furthermore, CD40-mediated enhancement of IL-4-driven germline Cepsilon; transcription was inhibited by antisense ODN for TRAF3 and by a MEK1 inhibitor, PD98059. These results suggest that in DG75 cells, TRAF3-induced MEK1 activation may be involved in CD40-mediated upregulation of IL-4-driven germline Cepsilon transcription, (C) 2002 Elsevier Science (USA) All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 22 条
[1]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[2]   Tumor necrosis factor receptor-associated factors (TRAFs) [J].
Bradley, JR ;
Pober, JS .
ONCOGENE, 2001, 20 (44) :6482-6491
[3]   Tumour-necrosis-factor-receptor-associated factor 6, NF-κB-inducing kinase and IκB kinases mediate IgE isotype switching in response to CD40 [J].
Brady, K ;
Fitzgerald, S ;
Moynagh, PN .
BIOCHEMICAL JOURNAL, 2000, 350 :735-740
[4]   An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-κB activation but is dispensable for c-Jun N-terminal kinase signaling [J].
Dadgostar, H ;
Cheng, GH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24775-24780
[5]  
Hsing Y, 1997, J IMMUNOL, V159, P4898
[6]   TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling [J].
Ishida, T ;
Tojo, T ;
Aoki, T ;
Kobayashi, N ;
Ohishi, T ;
Watanabe, T ;
Yamamoto, T ;
Inoue, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9437-9442
[7]   Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions [J].
Jalukar, SV ;
Hostager, BS ;
Bishop, GA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :623-630
[8]   TRAF2 is essential for JNK but not NF-kappa B activation and regulates lymphocyte proliferation and survival [J].
Lee, SY ;
Reichlin, A ;
Santana, A ;
Sokol, KA ;
Nussenzweig, MC ;
Choi, Y .
IMMUNITY, 1997, 7 (05) :703-713
[9]  
Leo E, 1999, EUR J IMMUNOL, V29, P3908, DOI 10.1002/(SICI)1521-4141(199912)29:12<3908::AID-IMMU3908>3.0.CO
[10]  
2-E